You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 89 No. 1, JANUARY 1952 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

INFECTIONS WITH PSEUDOMONAS AERUGINOSA TREATED WITH POLYMYXIN B

ERNEST JAWETZ, M.D., Ph.D.

AMA Arch Intern Med. 1952;89(1):90-98.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

PSEUDOMONAS aeruginosa derived its earlier name, Bacillus pyocyaneus, from the blue-green pus of wounds from which it was cultured. It is one of about 30 related species of Gram-negative bacilli which are predominantly freeliving in water and soil. Ps. aeruginosa is a normal inhabitant of the human intestinal tract, where it usually is present in small numbers and comes to the fore only when the normal coliform flora has been suppressed by antimicrobial drugs. This organism is not a pathogen in the usual sense of the word but may be called an "opportunist." It has no invasive powers and is ordinarily dealt with by the normal defenses of the body. Should these defenses not be developed, as in infants, or break down, as in debilitated persons, or should the bacillus be introduced passively into areas devoid of adequate natural defense mechanisms, it can set up an infection. Being closely related . . . [Full Text PDF of this Article]


Author Affiliations

SAN FRANCISCO

From the Divisions of Microbiology, Medicine, and Pediatrics, University of California School of Medicine.


Footnotes

This study was aided by a grant from Burroughs Wellcome & Company, Inc., Tuckahoe 7, N. Y., which issues polymyxin B as aerosporin.® Supplies of this brand of polymyxin B sulfate were generously made available by Dr. D. S. Searle, of Burroughs Wellcome & Company, Inc.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1952 American Medical Association. All Rights Reserved.